Neutral
Evotec SE's stock is under recent technical scrutiny due to signals like breaking below its 50-day moving average and a MACD short signal in early Jun...
Neutral
Evotec SE shares are currently trading around 4.60 euros, while analyst price targets range from 4.50 to 10 euros, showing divided views on the biotec...
Neutral
Evotec SE has re-entered the spotlight for US investors following its Nasdaq relisting and strategic updates. The company, which specializes in drug d...